S
Skinsfan1229
Guest
http://clinicaltrials.gov/show/NCT00338650
This trial is for.....
The primary objective of this study is to make adalimumab available to patients suffering from moderately to severely active Crohn’s Disease who have failed to respond to, lost response to, or are intolerant to infliximab, and to evaluate safety
This trial is at MULTIPLE locations around the United States, so should be within a short drive or so within everyones reach, if you qualify.
This trial is for.....
The primary objective of this study is to make adalimumab available to patients suffering from moderately to severely active Crohn’s Disease who have failed to respond to, lost response to, or are intolerant to infliximab, and to evaluate safety
This trial is at MULTIPLE locations around the United States, so should be within a short drive or so within everyones reach, if you qualify.